Omnimmune Holdings Overview

  • Status
  • Public
  • Employees
  • 2
  • Stock Symbol
  • OMMH
Stock Symbol
  • Investments
  • 1

Omnimmune Holdings General Information


Omnimmune Holdings Inc is a development-stage biotechnology company, which is engaged in integrating complementary cancer therapeutic, diagnostic and prognostic technologies.

Contact Information

Formerly Known As
Roughneck Supplies
Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • 4600 Post Oak Place
  • Suite 352
  • Houston, TX 77027
  • United States
+1 (713) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Omnimmune Holdings Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS

Omnimmune Holdings Financials Summary

In Thousands,
TTM 30-Sep-2010 FY 2009 31-Dec-2009 FY 2008 31-Dec-2008 FY 2007 31-May-2007
EV 2,592 3,694 5,289
Revenue 0 0 0
EBITDA (884)
Net Income (1,794) (1,761) (5,990) (9)
Total Assets 44 31 53 74
Total Debt 2,285 2,273 2,257
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Omnimmune Holdings Board Members (1)

Name Representing Role Since
0000 0000000 Self Chairman & Board Member 000 0000
To view Omnimmune Holdings’s complete board members history, request access »

Omnimmune Holdings Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omnimmune Holdings Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 000 07-Aug-2008 0000000000 Biotechnology
To view Omnimmune Holdings’s complete acquisitions history, request access »